Clinical Trial Update: Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat SGA Children With Short Stature [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for pegylated somatropin (PEG Somatropin) to treat short stature in children born small for gestational age; the study is currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Stature

Drugs mentioned

• Pegylated Somatropin (pegylated human growth hormone)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Short Stature Children Born Small for Gestational Age (SGA) | Phase 2 | Status: ACTIVE_NOT_RECRUITING